X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3747) 3747
Book Review (666) 666
Publication (395) 395
Newsletter (45) 45
Newspaper Article (26) 26
Book Chapter (16) 16
Book / eBook (11) 11
Conference Proceeding (8) 8
Dissertation (6) 6
Magazine Article (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3337) 3337
humans (2971) 2971
pneumonia (2044) 2044
male (1451) 1451
female (1428) 1428
infectious diseases (1221) 1221
staphylococcus aureus (1173) 1173
microbiology (1167) 1167
staphylococcal infections - microbiology (870) 870
bacterial pneumonia (844) 844
adult (840) 840
middle aged (826) 826
infections (801) 801
anti-bacterial agents - therapeutic use (779) 779
animals (719) 719
aged (695) 695
health aspects (574) 574
immunology (558) 558
staphylococcal infections - drug therapy (545) 545
antibiotics (533) 533
staphylococcus aureus - drug effects (512) 512
risk factors (501) 501
staphylococcus infections (488) 488
pneumonia, staphylococcal - microbiology (483) 483
staphylococcus aureus infections (483) 483
adolescent (480) 480
panton-valentine leukocidin (473) 473
bacteria (472) 472
abridged index medicus (470) 470
child (463) 463
mortality (440) 440
anti-bacterial agents - pharmacology (432) 432
microbial sensitivity tests (429) 429
research (428) 428
staphylococcal infections - epidemiology (425) 425
epidemiology (421) 421
staphylococcus aureus - isolation & purification (419) 419
infection (418) 418
mice (417) 417
community-acquired infections - microbiology (414) 414
pharmacology & pharmacy (412) 412
infant (394) 394
methicillin resistance (392) 392
child, preschool (391) 391
drug resistance in microorganisms (377) 377
drug resistance (366) 366
methicillin-resistant staphylococcus aureus - isolation & purification (364) 364
methicillin-resistant staphylococcus aureus (357) 357
mrsa (354) 354
ventilator-associated pneumonia (353) 353
cross infection - microbiology (352) 352
nosocomial infections (343) 343
pneumonia, staphylococcal - drug therapy (339) 339
retrospective studies (330) 330
analysis (326) 326
bacteremia (318) 318
research article (312) 312
aged, 80 and over (308) 308
vancomycin (306) 306
children (304) 304
virulence (304) 304
pneumonia - microbiology (302) 302
treatment outcome (301) 301
community-acquired pneumonia (300) 300
pathogens (299) 299
hospitals (295) 295
medicine (294) 294
respiratory system (293) 293
pneumonia, bacterial - microbiology (275) 275
staphylococcal infections (274) 274
methicillin-resistant staphylococcus aureus - drug effects (271) 271
staphylococcus aureus - genetics (269) 269
care and treatment (261) 261
pediatrics (259) 259
resistant staphylococcus-aureus (255) 255
methicillin-resistant (254) 254
prospective studies (249) 249
genes (246) 246
biochemical phenomena, metabolism, and nutrition (241) 241
strains (241) 241
cross infection (239) 239
diagnosis (237) 237
bacterial infections and mycoses (235) 235
staphylococcus aureus - pathogenicity (235) 235
united-states (231) 231
cross infection - epidemiology (228) 228
internal medicine (228) 228
cross infection - drug therapy (227) 227
disease (225) 225
young adult (220) 220
sepsis (213) 213
disease models, animal (210) 210
necrotizing pneumonia (210) 210
risk-factors (210) 210
staphylococcus-aureus (210) 210
community-acquired infections - epidemiology (206) 206
infant, newborn (205) 205
science (204) 204
prevalence (203) 203
intensive care units (201) 201
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3559) 3559
Russian (84) 84
Spanish (44) 44
French (42) 42
Japanese (35) 35
German (28) 28
Chinese (12) 12
Polish (11) 11
Turkish (5) 5
Ukrainian (5) 5
Danish (4) 4
Dutch (3) 3
Portuguese (3) 3
Czech (2) 2
Italian (2) 2
Norwegian (2) 2
Swedish (2) 2
Bulgarian (1) 1
Hebrew (1) 1
Hungarian (1) 1
Korean (1) 1
Lithuanian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 3/2012, Volume 54, Issue 5, pp. 621 - 629
Background. Post hoc analyses of clinical trial data suggested that linezolid may be more effective than vancomycin for treatment of methicillin-resistant... 
Staphylococcal pneumonia | Pneumonia | Health outcomes | Mortality | Methicillin resistant staphylococcus aureus | Ventilator associated pneumonia | Infections | ARTICLES AND COMMENTARIES | Nephrotoxicity | Staphylococcus aureus | Artificial respiration | UNITED-STATES | INFECTIOUS DISEASES | HOSPITALIZED-PATIENTS | INFECTIONS | MULTICENTER | VANCOMYCIN | VENTILATOR-ASSOCIATED PNEUMONIA | CARE-ASSOCIATED PNEUMONIA | DOUBLE-BLIND | MICROBIOLOGY | IMMUNOLOGY | EPIDEMIOLOGY | Linezolid | Humans | Methicillin-Resistant Staphylococcus aureus - drug effects | Middle Aged | Cross Infection - mortality | Male | Oxazolidinones - adverse effects | Treatment Outcome | Oxazolidinones - administration & dosage | Pneumonia, Staphylococcal - microbiology | Cross Infection - drug therapy | Oxazolidinones - therapeutic use | Anti-Bacterial Agents - therapeutic use | Pneumonia, Staphylococcal - drug therapy | Acetamides - therapeutic use | Pneumonia, Staphylococcal - mortality | Cross Infection - microbiology | Acetamides - adverse effects | Adult | Female | Aged | Anti-Bacterial Agents - adverse effects | Anti-Bacterial Agents - administration & dosage | Acetamides - administration & dosage | Usage | Ventilator-associated pneumonia | Patient outcomes | Research | Drug therapy | Staphylococcus infections | Infectious diseases | Antibiotics | Clinical outcomes | Index Medicus
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 7/2009, Volume 49, Issue 1, pp. 65 - 71
Background. The incidence of and outcomes associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in hospitalized children have been... 
Pediatrics | Databases | Mortality | Articles and Commentaries | Methicillin resistant staphylococcus aureus | Chronic diseases | Infections | Hospitalization | Children | Staphylococcus aureus | Child health services | SOFT-TISSUE INFECTIONS | INFECTIOUS DISEASES | RISK-FACTORS | PEDIATRIC-PATIENTS | DISEASE | MICROBIOLOGY | HOSPITALIZATIONS | PREVALENCE | SKIN | IMMUNOLOGY | EPIDEMIOLOGY | United States - epidemiology | Soft Tissue Infections - mortality | Pneumonia, Staphylococcal - epidemiology | Humans | Child, Preschool | Bacteremia - mortality | Infant | Male | Pneumonia, Staphylococcal - microbiology | Incidence | Bacteremia - microbiology | Female | Retrospective Studies | Staphylococcal Infections - microbiology | Osteomyelitis - epidemiology | Child | Staphylococcal Skin Infections - epidemiology | Treatment Outcome | Soft Tissue Infections - epidemiology | Osteomyelitis - mortality | Staphylococcal Infections - mortality | Hospitals | Soft Tissue Infections - microbiology | Staphylococcal Infections - epidemiology | Pneumonia, Staphylococcal - mortality | Osteomyelitis - microbiology | Adolescent | Staphylococcal Skin Infections - mortality | Bacteremia - epidemiology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Staphylococcal Skin Infections - microbiology | Forecasts and trends | Research | Children's hospitals | Staphylococcus aureus infections | Distribution | Studies | Infectious diseases | Staphylococcus infections | Drug resistance | Index Medicus
Journal Article
Science, ISSN 0036-8075, 2/2007, Volume 315, Issue 5815, pp. 1130 - 1133
The Staphylococcus aureus Panton-Valentine leukocidin (PVL) is a pore-forming toxin secreted by strains epidemiologically associated with the current outbreak... 
Bacteriophages | Up regulation | Staphylococcal pneumonia | Pneumonia | Lungs | Plasmids | Cell walls | Genes | Steepest descent method | Reports | Toxins | STRAINS | REGULATOR | SIGMA(B) | PROTEIN-A | GENE | MULTIDISCIPLINARY SCIENCES | RESISTANCE | EXPRESSION | Lung - microbiology | Virulence Factors - genetics | Oligonucleotide Array Sequence Analysis | Virulence Factors - physiology | Virulence | Pneumonia, Staphylococcal - pathology | Gene Expression Profiling | Pneumonia, Staphylococcal - microbiology | Hemorrhage | Necrosis | Leukocidins - physiology | Bacterial Toxins - genetics | Transcription, Genetic | Methicillin Resistance | Disease Models, Animal | Staphylococcal Protein A - genetics | Staphylococcus aureus - metabolism | Calcium-Binding Proteins - metabolism | Exotoxins - physiology | Leukocidins - genetics | Staphylococcus aureus - genetics | Lung - pathology | Bacterial Proteins - genetics | Staphylococcus aureus - pathogenicity | Animals | Exotoxins - genetics | Bacterial Proteins - metabolism | Mice | Mice, Inbred BALB C | Gene Expression Regulation, Bacterial | Staphylococcal Protein A - metabolism | Staphylococcus aureus - growth & development | Calcium-Binding Proteins - genetics | Physiological aspects | Bacterial infections | Research | Bacterial pneumonia | Staphylococcus aureus | Staphylococcus infections | Microbiology | Gene expression | Respiratory diseases | Index Medicus
Journal Article
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 10/2008, Volume 198, Issue 8, pp. 1166 - 1170
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 7/2013, Volume 208, Issue 1, pp. 75 - 82
Background. Linezolid is recommended for treatment of pneumonia and other invasive infections caused by methicillin-resistant Staphylococcus aureus (MRSA). The... 
Rabbits | Staphylococcal pneumonia | Pneumonia | Health outcomes | BACTERIA | Lungs | Methicillin resistant staphylococcus aureus | Infections | Toxins | Leukocidins | Staphylococcus aureus | Panton-Valentine leukocidin | treatment | linezolid | rabbit model | pneumonia | MRSA | vancomycin | protein synthesis inhibitor | alpha-hemolysin | INFECTIOUS DISEASES | COMMUNITY-ACQUIRED PNEUMONIA | INFECTIONS | ANTIBIOTICS | EFFICACY | MICROBIOLOGY | IMMUNOLOGY | VIRULENCE | GENES | DOUBLE-BLIND | CLOSTRIDIUM-PERFRINGENS | Linezolid | Bacterial Toxins - analysis | Methicillin-Resistant Staphylococcus aureus - drug effects | Lung - chemistry | Pneumonia, Staphylococcal - microbiology | Interleukin-8 - analysis | Bacterial Load - drug effects | Oxazolidinones - therapeutic use | Bacterial Toxins - antagonists & inhibitors | Anti-Bacterial Agents - therapeutic use | Bacterial Toxins - biosynthesis | Pneumonia, Staphylococcal - drug therapy | Animals | Acetamides - therapeutic use | Pneumonia, Staphylococcal - mortality | Vancomycin - therapeutic use | Leukocidins - analysis | Exotoxins - analysis | Hemolysin Proteins - analysis | Chemokine CCL2 - analysis | Disease Models, Animal | Exotoxins | Patient outcomes | Bacterial pneumonia | Staphylococcus aureus infections | Models | Dosage and administration | Research | Drug therapy | Index Medicus | Abridged Index Medicus | Major and Brief Reports
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 34, pp. 5099 - 5109
Highlights ► Vaccination against Staphylococcus aureus is achieved with toxoids. ► Toxoids are >107 inactivated and stimulate immunity to S. aureus . ►... 
Allergy and Immunology | Superantigen | Vaccine | Rabbit Model | Cytolysin | Staphylococcus aureus | ENTEROTOXIN-F | MEDICINE, RESEARCH & EXPERIMENTAL | BETA-TOXIN | STREPTOCOCCAL PYROGENIC EXOTOXIN | ALPHA-TOXIN | IMMUNOLOGY | METHICILLIN-RESISTANT | MEDICAL PROGRESS | PANTON-VALENTINE LEUKOCIDIN | TOXIC-SHOCK-SYNDROME | INFECTIVE ENDOCARDITIS | CLASS-II | Hemolysin Proteins - immunology | Adjuvants, Immunologic - administration & dosage | Superantigens - administration & dosage | Humans | Vaccination | Cytotoxins - administration & dosage | Male | Neutralization Tests | Pneumonia, Staphylococcal - microbiology | Shock, Septic - immunology | Shock, Septic - therapy | Hemolysin Proteins - administration & dosage | Endocarditis, Bacterial - microbiology | Female | Bacterial Proteins - immunology | Staphylococcal Infections - microbiology | Staphylococcal Toxoid - immunology | Staphylococcal Vaccines - immunology | Antibodies, Bacterial - blood | Pneumonia, Staphylococcal - immunology | Cell Line | Rabbits - immunology | Staphylococcal Infections - immunology | Bacterial Toxins - immunology | Exotoxins - immunology | Pneumonia, Staphylococcal - therapy | Endocarditis, Bacterial - immunology | Superantigens - immunology | Staphylococcus aureus - pathogenicity | Shock, Septic - microbiology | Staphylococcal Infections - therapy | Animals | Staphylococcal Toxoid - administration & dosage | Antibody Formation | Antibodies, Bacterial - immunology | Bacterial Toxins - administration & dosage | Staphylococcus aureus - immunology | Rabbits - microbiology | Cytotoxins - immunology | CD40 Antigens - immunology | Endocarditis, Bacterial - therapy | Rabbits | Medical colleges | Biological products | Staphylococcus aureus infections | Antibodies | Septic shock | Sulfates | T cells | Viral antibodies | Surface active agents | Immunotherapy | Mitogens | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2014, Volume 58, Issue 2, pp. 1108 - 1117
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2010, Volume 107, Issue 12, pp. 5587 - 5592
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is epidemic in the United States, even rivaling HIV/AIDS in its public health... 
Acute lung injury | Pneumonia | Staphylococcal pneumonia | Lungs | Neutrophils | Sprains and strains | Infections | Toxins | Leukocidins | Staphylococcus aureus | USA300 | Virulence | MRSA | Rabbit infection model | VIRULENCE DETERMINANT | INFECTIONS | HUMAN NEUTROPHILS | MULTIDISCIPLINARY SCIENCES | TOXINS | NECROTIZING PNEUMONIA | rabbit infection model | COMMUNITY-ONSET PNEUMONIA | IN-VITRO | virulence | pneumonia | GENERATION | SKIN | BINDING | Humans | Bacterial Toxins - toxicity | Pneumonia, Staphylococcal - pathology | Pneumonia, Staphylococcal - microbiology | Genetic Complementation Test | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Pneumonia, Staphylococcal - etiology | Virulence - genetics | Gene Deletion | Leukocidins - toxicity | Bacterial Toxins - genetics | Methicillin-Resistant Staphylococcus aureus - genetics | Disease Models, Animal | Neutrophils - pathology | Leukocidins - genetics | Genes, Bacterial | Rabbits | Neutrophils - drug effects | Neutrophils - physiology | Acute Lung Injury - pathology | Acute Lung Injury - microbiology | Animals | Exotoxins - genetics | Exotoxins - toxicity | In Vitro Techniques | Acute Lung Injury - etiology | Physiological aspects | Causes of | Development and progression | Leukocytes | Staphylococcus aureus infections | Epidemics | Leucocytes | Rodents | Cloning | Human immunodeficiency virus--HIV | Staphylococcus infections | Public health | Index Medicus | Cytolysis | Edema | Animal models | Lung | Cytotoxicity | Data processing | Inflammation | Drug resistance | Hemorrhage | leukocidin | Necrosis | Infection | Hemoptysis | Acquired immune deficiency syndrome | Granules | Leukocytes (polymorphonuclear) | Alveoli | pandemics | Injuries | Biological Sciences
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 2014, Volume 209, Issue 6, pp. 865 - 875
Journal Article